Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Safe Group AB
AB
Active
Org 5592971724
Batterigatan 5 K, 721 37
Västerås
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2021 · 5 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Safe Group AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
5M
7M
9M
8M
2021
1M
2022
2M
2023
3M
2024
EBITDA
SEK millions
6M
4M
2M
-0M
-3M
5M
2021
0M
-100%
2022
-2M
-200%
2023
0M
+100%
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
7 915
983
1 955
3 490
Staff expenses
—
−274
−1 594
−590
EBITDA
4 771
−480
−1 637
390
Depreciation & amort.
−49
−231
−58
−58
EBIT
4 722
−711
−1 695
332
Net financials
—
−15
−39
2
Profit before tax
3 542
75
−1 354
334
Tax
−730
−17
—
—
Net profit
2 812
58
−1 354
334
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
6 100
5 331
1 791
2 250
Equity
2 837
2 708
1 353
1 888
Long-term debt
0
670
0
—
Short-term debt
2 083
1 574
438
363
Total debt
2 083
2 244
438
363
Financial ratios
5-year trend
EBITDA margin
11.2%
This company
15.8%
Market median
-29% vs market
2021
2024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
2021
2024
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
2021
2024
Net profit margin
9.6%
This company
8.1%
Market median
+19% vs market
2021
2024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
2021
2024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Safe Group AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
